You have 9 free searches left this month | for more free features.

Condition

Blood Cancer (1)

CLL (1)

Graft Versus Host Disease (1)

Hodgkin's Disease (1)

Leukemia (1)

MDS (1)

Malignancy (1)

Multiple Sclerosis (1)

NHL (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Genzyme, a Sanofi Company (1)

Stanford University (1)

Collaborator

Study Documents

Intervention Type

drug (2)

procedure (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

diphenydramine

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Multiple Sclerosis Trial in Worldwide (Alemtuzumab GZ402673, Glatiramer acetate, Beta-Interferon)

Active, not recruiting

Multiple Sclerosis

Alemtuzumab GZ402673
+11 more

Wien, Austria
+20 more

Jun 16, 2022

Blood Cancer, Leukemia, GVHD Trial in Stanford (non-myeloablative hematopoietic cell transplantation, Anti-Thymocyte Globulin,

Completed

Blood Cancer
+7 more

non-myeloablative hematopoietic cell transplantation
+8 more

Stanford, California

Stanford University School of Medicine

Nov 17, 2019